Dofetilide 0.125 MG Oral Capsule — RxCUI 310003
RxNorm drug concept · Semantic clinical drug
RxCUI 310003
Semantic clinical drug · SCD
● Current RxNorm concept 36 FDA products
48 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310003
Official nameDofetilide 0.125 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdofetilide 125 MCG Oral Capsule
FDA products mapped36
Package NDCs mapped48
Reported Medicaid activity (SDUD)10,363 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dofetilide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dofetilide can cause a serious, potentially life-threatening heart rhythm problem called Torsade de Pointes, especially in the first few days of treatment. The hospital stay — at l...
- Why do I have to stay in the hospital just to start this pill?
- You need to check before taking anything new — even over-the-counter medications. For example, cimetidine (a common heartburn drug found in some antacids) is completely off-limits...
- Can I take my usual heartburn or allergy medicine while on dofetilide?
🕸️ Concept Web — How Dofetilide 0.125 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dofetilide 0.125 MG Oral Capsule
RxCUI 310003 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dofetilide
49247IN
-
Dofetilide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Tikosyn
261672BN
-
Tikosyn
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dofetilide Oral Capsule
374623SCDF -
Dofetilide Oral Product
1160620SCDG -
Dofetilide Pill
1160621SCDG -
Dofetilide Oral Capsule [Tikosyn]
366556SBDF -
Tikosyn Oral Product
1178508SBDG -
Tikosyn Pill
1178509SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Dofetilide Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dofetilide 0.125 MG
330323SCDC -
Dofetilide 0.125 MG Oral Capsule [Tikosyn]
284404SBD -
Dofetilide 0.125 MG [Tikosyn]
574844SBDC
-
Dofetilide 0.125 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dofetilide 0.125 MG
SCDC · 330323 -
Dofetilide Oral Capsule
SCDF · 374623 -
Dofetilide Oral Product
SCDG · 1160620 -
Dofetilide Pill
SCDG · 1160621
Brand-Name Concepts
-
Dofetilide 0.125 MG Oral Capsule [Tikosyn]
SBD · 284404 -
Dofetilide 0.125 MG [Tikosyn]
SBDC · 574844 -
Dofetilide Oral Capsule [Tikosyn]
SBDF · 366556 -
Tikosyn Oral Product
SBDG · 1178508 -
Tikosyn Pill
SBDG · 1178509 -
Tikosyn
BN · 261672
📦 FDA Products & Package NDCs
36 products · 48 package NDCs
48 package NDCs map to RxCUI 310003 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00069-5800-60 | 60 CAPSULE in 1 BOTTLE (0069-5800-60) | Tikosyn | Pfizer Laboratories Div Pfizer Inc | 1999-10-01 |
| 00069-5800-61 | 14 CAPSULE in 1 BOTTLE (0069-5800-61) | Tikosyn | Pfizer Laboratories Div Pfizer Inc | 1999-10-01 |
| 00069-5810-60 | 60 CAPSULE in 1 BOTTLE (0069-5810-60) | Tikosyn | Pfizer Laboratories Div Pfizer Inc | 1999-10-01 |
| 00069-5810-61 | 14 CAPSULE in 1 BOTTLE (0069-5810-61) | Tikosyn | Pfizer Laboratories Div Pfizer Inc | 1999-10-01 |
| 00069-5820-60 | 60 CAPSULE in 1 BOTTLE (0069-5820-60) | Tikosyn | Pfizer Laboratories Div Pfizer Inc | 1999-10-01 |
| 00069-5820-61 | 14 CAPSULE in 1 BOTTLE (0069-5820-61) | Tikosyn | Pfizer Laboratories Div Pfizer Inc | 1999-10-01 |
| 00904-7522-08 | 40 BLISTER PACK in 1 CARTON (0904-7522-08) / 1 CAPSULE in 1... | Dofetilide | Major Pharmaceuticals | 2024-10-17 |
| 00904-7523-08 | 40 BLISTER PACK in 1 CARTON (0904-7523-08) / 1 CAPSULE in 1... | Dofetilide | Major Pharmaceuticals | 2024-10-17 |
| 00904-7524-08 | 40 BLISTER PACK in 1 CARTON (0904-7524-08) / 1 CAPSULE in 1... | Dofetilide | Major Pharmaceuticals | 2024-10-17 |
| 16729-0490-12 | 60 CAPSULE in 1 BOTTLE (16729-490-12) | Dofetilide | Accord Healthcare, Inc. | 2020-08-20 |
| 16729-0491-12 | 60 CAPSULE in 1 BOTTLE (16729-491-12) | Dofetilide | Accord Healthcare, Inc. | 2020-08-20 |
| 16729-0492-12 | 60 CAPSULE in 1 BOTTLE (16729-492-12) | Dofetilide | Accord Healthcare, Inc. | 2020-08-20 |
| 42794-0044-10 | 60 CAPSULE in 1 BOTTLE, PLASTIC (42794-044-10) | Dofetilide | Sigmapharm Laboratories, LLC | 2018-06-11 |
| 42794-0045-10 | 60 CAPSULE in 1 BOTTLE, PLASTIC (42794-045-10) | Dofetilide | Sigmapharm Laboratories, LLC | 2018-06-11 |
| 42794-0046-10 | 60 CAPSULE in 1 BOTTLE, PLASTIC (42794-046-10) | Dofetilide | Sigmapharm Laboratories, LLC | 2018-06-11 |
| 47335-0061-79 | 4 BLISTER PACK in 1 CARTON (47335-061-79) / 10 CAPSULE in 1... | DOFETILIDE | Sun Pharmaceutical Industries, Inc. | 2018-10-11 |
| 47335-0061-86 | 60 CAPSULE in 1 BOTTLE (47335-061-86) | DOFETILIDE | Sun Pharmaceutical Industries, Inc. | 2018-10-11 |
| 47335-0062-79 | 4 BLISTER PACK in 1 CARTON (47335-062-79) / 10 CAPSULE in 1... | DOFETILIDE | Sun Pharmaceutical Industries, Inc. | 2018-10-11 |
| 47335-0062-86 | 60 CAPSULE in 1 BOTTLE (47335-062-86) | DOFETILIDE | Sun Pharmaceutical Industries, Inc. | 2018-10-11 |
| 47335-0063-79 | 4 BLISTER PACK in 1 CARTON (47335-063-79) / 10 CAPSULE in 1... | DOFETILIDE | Sun Pharmaceutical Industries, Inc. | 2018-10-11 |
| 47335-0063-86 | 60 CAPSULE in 1 BOTTLE (47335-063-86) | DOFETILIDE | Sun Pharmaceutical Industries, Inc. | 2018-10-11 |
| 59651-0118-05 | 500 CAPSULE in 1 BOTTLE (59651-118-05) | Dofetilide | Aurobindo Pharma Limited | 2019-01-22 |
| 59651-0118-60 | 60 CAPSULE in 1 BOTTLE (59651-118-60) | Dofetilide | Aurobindo Pharma Limited | 2019-01-22 |
| 59651-0119-05 | 500 CAPSULE in 1 BOTTLE (59651-119-05) | Dofetilide | Aurobindo Pharma Limited | 2019-01-22 |
| 59651-0119-60 | 60 CAPSULE in 1 BOTTLE (59651-119-60) | Dofetilide | Aurobindo Pharma Limited | 2019-01-22 |
| 59651-0120-05 | 500 CAPSULE in 1 BOTTLE (59651-120-05) | Dofetilide | Aurobindo Pharma Limited | 2019-01-22 |
| 59651-0120-60 | 60 CAPSULE in 1 BOTTLE (59651-120-60) | Dofetilide | Aurobindo Pharma Limited | 2019-01-22 |
| 69452-0131-17 | 60 CAPSULE in 1 BOTTLE (69452-131-17) | Dofetilide | Bionpharma Inc. | 2018-04-11 |
| 69452-0132-17 | 60 CAPSULE in 1 BOTTLE (69452-132-17) | Dofetilide | Bionpharma Inc. | 2018-04-11 |
| 69452-0133-17 | 60 CAPSULE in 1 BOTTLE (69452-133-17) | Dofetilide | Bionpharma Inc. | 2018-04-11 |
| 70010-0024-06 | 60 CAPSULE in 1 BOTTLE (70010-024-06) | Dofetilide 0.125mg | Granules Pharmaceuticals Inc. | 2024-11-14 |
| 70010-0025-06 | 60 CAPSULE in 1 BOTTLE (70010-025-06) | Dofetilide 0.25mg | Granules Pharmaceuticals Inc. | 2024-11-14 |
| 70010-0026-06 | 60 CAPSULE in 1 BOTTLE (70010-026-06) | Dofetilide 0.5mg | Granules Pharmaceuticals Inc. | 2024-11-14 |
| 72205-0039-37 | 4 BLISTER PACK in 1 CARTON (72205-039-37) / 10 CAPSULE in 1... | Dofetilide | Novadoz Pharmaceuticals LLC | 2020-06-12 |
| 72205-0039-60 | 60 CAPSULE in 1 BOTTLE (72205-039-60) | Dofetilide | Novadoz Pharmaceuticals LLC | 2020-06-12 |
| 72205-0040-37 | 4 BLISTER PACK in 1 CARTON (72205-040-37) / 10 CAPSULE in 1... | Dofetilide | Novadoz Pharmaceuticals LLC | 2020-06-12 |
| 72205-0040-60 | 60 CAPSULE in 1 BOTTLE (72205-040-60) | Dofetilide | Novadoz Pharmaceuticals LLC | 2020-06-12 |
| 72205-0041-37 | 4 BLISTER PACK in 1 CARTON (72205-041-37) / 10 CAPSULE in 1... | Dofetilide | Novadoz Pharmaceuticals LLC | 2020-06-12 |
| 72205-0041-60 | 60 CAPSULE in 1 BOTTLE (72205-041-60) | Dofetilide | Novadoz Pharmaceuticals LLC | 2020-06-12 |
| 72603-0130-01 | 60 CAPSULE in 1 BOTTLE (72603-130-01) | DOFETILIDE | NorthStar RxLLC | 2023-02-07 |
| 72603-0131-01 | 60 CAPSULE in 1 BOTTLE (72603-131-01) | DOFETILIDE | NorthStar RxLLC | 2023-02-07 |
| 72603-0132-01 | 60 CAPSULE in 1 BOTTLE (72603-132-01) | DOFETILIDE | NorthStar RxLLC | 2023-02-07 |
| 75907-0054-60 | 60 CAPSULE in 1 BOTTLE, PLASTIC (75907-054-60) | Dofetilide | Dr. Reddy's Labratories Inc. | 2024-05-28 |
| 75907-0055-60 | 60 CAPSULE in 1 BOTTLE, PLASTIC (75907-055-60) | Dofetilide | Dr. Reddy's Labratories Inc. | 2024-05-28 |
| 75907-0056-60 | 60 CAPSULE in 1 BOTTLE, PLASTIC (75907-056-60) | Dofetilide | Dr. Reddy's Labratories Inc. | 2024-05-28 |
| 76282-0755-60 | 60 CAPSULE in 1 BOTTLE (76282-755-60) | Dofetilide | EXELAN PHARMACEUTICALS, INC. | 2024-11-01 |
| 76282-0756-60 | 60 CAPSULE in 1 BOTTLE (76282-756-60) | Dofetilide | EXELAN PHARMACEUTICALS, INC. | 2024-11-01 |
| 76282-0757-60 | 60 CAPSULE in 1 BOTTLE (76282-757-60) | Dofetilide | EXELAN PHARMACEUTICALS, INC. | 2024-11-01 |
Observed labelers:
Aurobindo Pharma Limited (6) ·
Novadoz Pharmaceuticals LLC (6) ·
Pfizer Laboratories Div Pfizer Inc (6) ·
Sun Pharmaceutical Industries, Inc. (6) ·
Accord Healthcare, Inc. (3) ·
Bionpharma Inc. (3)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.